Search results for "Insulin"

showing 10 items of 1360 documents

Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients.

2000

In order to assess the efficacy of gemfibrozil on lipid and haemostatic parameters in patients with plurimetabolic syndrome, a multicenter double-blind placebo controlled, parallel study was carried out in 56 patients with primary hypertriglyceridemia and glucose intolerance. These patients had elevated PAI activity and antigen and t-PA antigen levels at rest and after venous occlusion. Gemfibrozil reduced plasma triglyceride levels (P0.001), whereas it increased free fatty acids (P0.05) and high density lipoprotein cholesterol levels (P0.05). In those patients reaching normalization of plasma triglyceride levels (triglyceride reductionor =50%) (n=15), insulin levels (P0.05) as well as the …

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentFatty Acids NonesterifiedPlaceboFibrinogenInsulin resistanceDouble-Blind MethodInternal medicinemedicineGemfibrozilHumansInsulinAgedHypolipidemic AgentsHypertriglyceridemiaHemostasisbusiness.industryT-plasminogen activatorInsulinHypertriglyceridemiaParallel studyGlucose Tolerance TestMiddle Agedmedicine.diseaseEndocrinologyGemfibrozilInsulin ResistanceCardiology and Cardiovascular Medicinebusinessmedicine.drugAtherosclerosis
researchProduct

Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk fa…

2013

Abstract STUDY QUESTION: What alters cardiovascular and metabolic risk factors with aging in women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: Lipid parameters, mainly low-density lipoprotein (LDL) cholesterol, increase with aging, but not in women who attain ovulatory cycles. WHAT IS KNOWN ALREADY: Cardiovascular and metabolic parameters tend to increase with aging, but this has not been shown in a prospective longitudinal study in women with PCOS. Correlates of these changes have not been identified. STUDY DESIGN: A prospective cohort of 118 hyperandrogenic women with PCOS who were followed from the age of 20-25 years at 5 year intervals for 20 years. PARTICIPANTS/MATERIALS, SE…

AdultBlood GlucoseOvulationmedicine.medical_specialtyWaistSettore MED/09 - Medicina Internamedia_common.quotation_subjectmedicine.medical_treatmentBiologyBody Mass IndexSettore MED/13 - EndocrinologiaRisk FactorsInternal medicineTotal cholesterolPrevalencemedicineHumansInsulinLongitudinal StudiesGonadal Steroid HormonesOvulationmedia_commonMetabolic SyndromeCompeting interestsInsulinPolycystic ovary syndrome (PCOS)RehabilitationMetabolic riskAge Factorsnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseaseLipidsSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyReproductive MedicineCardiovascular DiseasesPCOS Cardiovascular risk aging hyperandrogenism ovarian function lipid alterationsFemalelipids (amino acids peptides and proteins)Waist CircumferenceMetabolic syndromePolycystic Ovary Syndrome
researchProduct

The effects of equal caloric amounts of xylitol, sucrose and starch on insulin requirements and blood glucose levels in insulin-dependent diabetics

1981

Xylitol has been suggested as a potentially useful sweetener in the diabetic diet. In 14 insulin-dependent diabetics a standard diabetic diet regimen was compared with diets in which starch was isocalorically exchanged in the breakfast meal by either 30 g xylitol or 30 g sucrose. Insulin requirement and blood glucose were measured using a glucose-controlled insulin infusion system. The results following breakfast with xylitol were similar to those after starch breakfasts. Sucrose, in contrast, induced a greater post-prandial rise in blood glucose levels despite counter-regulation by the glucose-controlled insulin infusion system. Insulin requirement after sucrose significantly exceeded (p l…

AdultBlood GlucoseSucroseSucroseStarchEndocrinology Diabetes and Metabolismmedicine.medical_treatmentXylitolArtificial pancreaschemistry.chemical_compoundDiabetes mellitusDietary CarbohydratesInternal MedicinemedicineHumansInsulinFood scienceXylitolMealC-PeptideChemistryInsulindigestive oral and skin physiologyfood and beveragesStarchmedicine.diseasecarbohydrates (lipids)Diabetes Mellitus Type 1Diabetic dietEnergy IntakeDiabetologia
researchProduct

The basal energy expenditure of female athletes vs. sedentary women as related to their family history of type 2 diabetes

2001

The purpose of this study was to investigate the basal metabolic rate (BMR) in 16 professional sportswomen (soccer players) versus 15 sedentary women, as related to the presence (FH+) or absence (FH-) of a family history of type 2 diabetes. The sportswomen, in toto, had a significantly higher BMR than expected from predictive equations (+14.92%). However, the difference was limited only to FH- sportswomen (+18.66%, p<0.0005). FH- sportswomen showed a significantly higher measured BMR than FH+ sportswomen (p<0.005), and FH+ (p=0.058) and than FH- (p<0.05) sedentary women. There were no other significant differences relative to physical, metabolic and plasmatic data between the groups. The sp…

AdultBlood Glucosemedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismEnergetic costPhysical exerciseType 2 diabetesOxygen ConsumptionEndocrinologyDiabetes mellitusInternal medicineSoccerInternal MedicinemedicineHumansInsulinFamily historyExercisebiologybusiness.industryAthletesNon insulin dependent diabetes mellitusGeneral Medicinemedicine.diseasebiology.organism_classificationEndocrinologyDiabetes Mellitus Type 2Basal metabolic rateBody CompositionFemaleBasal MetabolismEnergy MetabolismbusinessSportsActa Diabetologica
researchProduct

Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus

1990

A clinical trial was undertaken to determine whether intensive thymopentin administration enhances remission of insulin-dependent diabetes (IDDM) during the first year after diagnosis. Dosage with insulin was minimized with target control of blood glucose levels less than or equal to 7.8 mmol/l before meals. Remission was defined as a prolonged period after IDDM onset (not less than 3 months) characterized by a non-insulin-receiving (NIR) state in which target metabolic control was reached without administration of insulin and with a valid C-peptide response, evaluated after standard breakfast. Sixteen IDDM patients aged 12-31 years, recruited within 2 weeks of initiation of insulin therapy…

AdultBlood Glucosemedicine.medical_specialtyAdolescentmedicine.medical_treatmentImmunologyGastroenterologyInternal medicineDiabetes mellitusmedicineHumansInsulinImmunology and AllergyThymopentinChildGlycemicImmunity CellularC-Peptidebusiness.industryInsulinRemission InductionHemoglobin AReceptors Interleukin-2medicine.diseaseClinical trialTiterDiabetes Mellitus Type 1EndocrinologyChild PreschoolInsulin dependent diabetesMetabolic control analysisThymopentinbusinessmedicine.drugJournal of Autoimmunity
researchProduct

Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome

2014

ObjectiveOn the basis of the known diabetes risk in polycystic ovary syndrome (PCOS), recent guidelines of the Endocrine Society recommend the use of an oral glucose tolerance test (OGTT) to screen for impaired glucose tolerance (IGT) and type 2 diabetes (T2DM) in all women with PCOS. However, given the high prevalence of PCOS, OGTT would have a high cost–benefit ratio. In this study, we identified, through a receiver operating characteristic analysis, simple predictive markers of the composite endpoint (impaired fasting glucose (IFG) or IGT or IFG+IGT or T2DM) in women with PCOS according to the Rotterdam criteria.DesignWe conducted a cross-sectional study of 241 women with PCOS in a unive…

AdultBlood Glucosemedicine.medical_specialtyDiabetes riskWaistendocrine system diseasesAdolescentEndocrinology Diabetes and MetabolismType 2 diabetesIntra-Abdominal FatSettore MED/13 - EndocrinologiaImpaired glucose toleranceYoung AdultInsulin resistanceEndocrinologyAdiposity; Adolescent; Adult; Biological Markers; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus Type 2; Female; Humans; Intra-Abdominal Fat; Polycystic Ovary Syndrome; Risk Factors; Young Adult; Endocrinology; Endocrinology Diabetes and Metabolism; Medicine (all)Risk FactorsInternal medicineDiabetes mellitusmedicineHumansAdiposityCross-Sectional Studiebusiness.industryRisk FactorMedicine (all)nutritional and metabolic diseasesGeneral MedicineImpaired fasting glucosemedicine.diseasePolycystic ovaryCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2Biological MarkerFemalebusinessBiomarkersHumanPolycystic Ovary Syndrome
researchProduct

Ethnic differences in serum lipoproteins and their determinants in South African women.

2010

The objective of the study was to characterize ethnic differences in lipid levels and low-density lipoprotein (LDL) particle size and subclasses in black and white South African women and to explore the associations with insulin sensitivity (S(I)), body composition, and lifestyle factors. Fasting serum lipids and LDL size and subclasses, body composition (dual-energy x-ray absorptiometry), and S(I) (frequently sampled intravenous glucose tolerance test) were measured in normal-weight (body mass index25 kg/m(2)) black (n = 15) and white (n = 15), and obese (body mass index30 kg/m(2)) black (n = 13) and white (n = 13) women. Normal-weight and obese black women had lower triglycerides (0.59 +/…

AdultBlood Glucosemedicine.medical_specialtyEndocrinology Diabetes and MetabolismLipoproteinsBlood lipidsBlack PeopleMotor ActivityStatistics NonparametricBody Mass Indexchemistry.chemical_compoundSouth AfricaEndocrinologyHigh-density lipoproteinInternal medicineMedicineHumansInsulinObesityTriglyceridesBlack womenImmunoassayTriglyceridebusiness.industryCholesterolPatient SelectionEndocrinologychemistrySocioeconomic FactorsLow-density lipoproteinBody CompositionRegression Analysislipids (amino acids peptides and proteins)FemaleDietary ProteinsInsulin ResistancebusinessBody mass indexLipoproteinMetabolism: clinical and experimental
researchProduct

Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients

1985

The authors have studied insulin receptors on peripheral blood monocytes and insulin sensitivity, evaluated by simultaneous infusion of glucose, insulin and somatostatin in 10 control subjects and in 20 obese patients with normal glucose tolerance. The obese patients have been divided into two groups, normo (NO) and hyperinsulinemic (HO), according to the total insulin response during OGTT. We considered HO patients with insulin response higher than M + 2DS of controls. Obese patients showed, in comparison to the controls, a lower specific binding and higher degree of insulin resistance. The subdivision of obese patients allowed us to distinguish two groups. The first was characterized by b…

AdultBlood Glucosemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiologyGlucagonchemistry.chemical_compoundEndocrinologyInsulin resistanceHyperinsulinismInternal medicinemedicineHyperinsulinemiaHumansInsulinObesityGlucose tolerance testC-Peptidemedicine.diagnostic_testC-peptideInsulinGlucose Tolerance TestMiddle AgedGlucagonmedicine.diseaseReceptor InsulinInsulin receptorEndocrinologychemistrybiology.proteinInsulin ResistanceHyperinsulinismJournal of Endocrinological Investigation
researchProduct

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

2008

BACKGROUND: Insulin glargine is a once-daily basal insulin analog with prolonged duration of action and absence of an evident peak. Glargine is associated with reduced frequency of hypoglycemic episodes (mostly nocturnal) as well as effective glycemic control. Maintenance of good metabolic control before conception and throughout pregnancy is essential to lower the risk of fetal malformations. Glargine might be a valuable alternative in the management of pregnancies complicated by diabetes mellitus. However, because its clinical utility has not been established, the use of glargine is not currently recommended during pregnancy. OBJECTIVE: The aim of this study was to retrospectively evaluat…

AdultBlood Glucosemedicine.medical_specialtyInsulin IsophanePregnancy in DiabeticsInsulin GlargineSettore MED/13 - EndocrinologiaInsulin aspartPregnancyDiabetes mellitusInternal medicinemedicineOutpatient clinicInsulin lisproHumansHypoglycemic AgentsInsulinPharmacology (medical)Body Weights and MeasuresFemurInsulin AspartGlycemicRetrospective StudiesPharmacologyGlycated HemoglobinType 1 diabetesPregnancyInsulin LisproInsulin glarginebusiness.industryglargine type 1 diabetesPregnancy Outcomemedicine.diseaseInsulin Long-ActingEndocrinologyDiabetes Mellitus Type 1Case-Control StudiesFemalebusinessmedicine.drugClinical therapeutics
researchProduct

Placental infiltration of inflammatory markers in gestational diabetic women.

2013

Gestational diabetes mellitus (GDM) is pathology of glucose intolerance during pregnancy. It is influenced by maternal hyperglycemia and insulinemia through placental circulation. The study was undertaken to investigate the implication of pro-inflammatory factors in the placenta of GDM women. Thirty GDM women have delivered macrosomic babies, and 30 healthy age-matched pregnant women have delivered non macrosomic babies, were recruited in the study. The mRNAs encoding for IL-6, TLR4, TGF-β, CD68, CD14, EMR-1, CCL2, TCR-α, T-bet, GATA-3, leptin and adiponectin were quantified in placental samples by using RT-qPCR. The mRNA expression of the pro-inflammatory factors, i.e., IL-6, TLR4 and TGF-…

AdultBlood Glucosemedicine.medical_specialtyendocrine system diseasesAdolescentPhysiologyPlacentaBiophysicsBiologyYoung AdultPregnancyInternal medicinePlacentaDiabetes mellitusmedicineHumansInsulinRNA Messengerreproductive and urinary physiologyGlycated HemoglobinInflammationPregnancyAdiponectinPlacental CirculationLeptinnutritional and metabolic diseasesGeneral Medicinemedicine.diseasefemale genital diseases and pregnancy complicationsGestational diabetesDiabetes GestationalEndocrinologymedicine.anatomical_structureGene Expression Regulationembryonic structuresGestationFemaleBiomarkersGeneral physiology and biophysics
researchProduct